🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study was designed to investigate the 1 year efficacy and safety of th...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-06
Trial ID
NCT00929110
Treatments Being Tested
The purpose of this study is to evaluate the safety and the efficacy of Gly...
Status
Completed
Location
Medicines Evaluation Unit
Start Date
2010-08
Trial ID
NCT01176903
Treatments Being Tested
This study aims to compare the efficacy of three therapies for chronic obst...
Status
Unknown
Location
The First Affiliated Hospital of Henan University of Traditional Chinese Medicine
Start Date
2017-05
Trial ID
NCT03169504
Treatments Being Tested
The primary objective of this trial was to establish non-inferiority of lun...
Status
Completed
Location
Multiple Locations
Start Date
2005-07-28
Trial ID
NCT02242266
The primary objective of this study is to assess the efficacy of Glycopyrro...
Status
Completed
Location
Pearl Investigative Site
Start Date
2012-04
Trial ID
NCT01587079
Treatments Being Tested
The purpose of this study is to determine if tiotropium Respimat will resul...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-05-01
Trial ID
NCT05838703
The primary objective is to compare the efficacy of UMEC/VI Inhalation Powd...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-09-15
Trial ID
NCT01899742
Treatments Being Tested
This is a descriptive observational open non-comparative study of the safet...
Status
Completed
Location
Boehringer Ingelheim Investigational Site 1
Start Date
2004-03
Trial ID
NCT00620516
To compare the bronchodilator efficacy and safety of tiotropium inhalation ...
Status
Completed
Location
Multiple Locations
Start Date
2001-05
Trial ID
NCT02172469
This study is to characterize the pharmacodynamic characteristics and to as...
Status
Completed
Location
Investigational Site 203
Start Date
2022-03-24
Trial ID
NCT05161156